Michael Saylor is the executive chairman and co-founder of MicroStrategy, a company that issues equity and debt to buy ...

Bitcoin (BTC-USD) on Saturday was hovering just under the historic $100K milestone, taking a bit of a breather after another ...

Most major global financial assets have reacted as largely expected to Donald Trump's victory in the U.S. presidential ...

Altcoin season looms as TOTAL3 hits $936B and Layer 1 tokens rally. Pro-crypto sentiment and rising spot volumes drive market momentum.

Bitcoin prediction markets still see $100,000 hitting by New Year despite mounting BTC price selling pressure.

Discover how the YieldMax MSTR Option Income Strategy ETF (MSTY) maximizes gains through call-option-selling strategy in high ...

Shubham Pant, MD, MBBS, discussed the use of zanidatamab and the HERIZON-BTC-01 trial in HER2-positive biliary tract cancer ...

Analyzing the risks and benefits of investing in MSTY and MSTR in a volatile market influenced by BTC/USD movements.

Bitcoin flirts with $100K after SEC Chair Gary Gensler announces resignation. Anthony Pompliano calls the timing "poetic" for ...

If the Senate confirms Bessent, the next person whose signature is on the front of paper U.S. currency will be a fan of ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...